Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$112.66
pos +0.00
+0.00%
Today's Range: 112.42 - 114.75 | CELG Avg Daily Volume: 5,023,700
Last Update: 01/20/17 - 4:00 PM EST
Volume: 0
YTD Performance: -2.67%
Open: $0.00
Previous Close: $113.62
52 Week Range: $93.05 - $127.00
Oustanding Shares: 775,203,498
Market Cap: 88,078,621,443
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 15 14 15 14
Moderate Buy 0 0 0 0
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.24 1.25 1.33 1.35
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 43.20
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
43.20 47.70 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.64% 4.81% 34.89%
GROWTH 12 Mo 3 Yr CAGR
Revenue 20.70 0.70 0.19
Net Income -19.90 0.10 0.03
EPS -18.80 0.20 0.06
Earnings for CELG:
EBITDA 2.96B
Revenue 9.26B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.43 $1.44 $5.28 $6.47
Number of Analysts 4 2 5 3
High Estimate $1.43 $1.46 $5.30 $6.52
Low Estimate $1.42 $1.41 $5.27 $6.44
Prior Year $1.00 $1.18 $4.08 $5.28
Growth Rate (Year over Year) 42.75% 21.61% 29.51% 22.45%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Jan 19, 2017 | 4:13 PM EST
The U.S. dollar weakened. The price of crude oil rose by about two bits to $51.40. Gold fell by $8 to $1,203. I am buyer, to replace the half position I sold soon. Ag commodities: wheat down $0.08, corn up $0.02, soybean down $0.05 and oats up $0.01. Lumber was flat. For the second day in a row bonds got schmeissed iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down over a beaner, again. (Good sale in fixed income last week!) The 10-year bond yield rose by 7 basis points to 2.46%. The long bond yield rose by 5 basis points. The 2s/10s expanded by 4 basis points to about 124 basis points. Municipals got hit and so did closed-end muni-bond funds. High yield was junky - but Blackstone / GSO Strategic Credit Fund (BGB) rose by a penny. Banks continue to be sold for a second day in a row -- despite much higher bond yields and lower bond prices. Crickets from financial bulls -- who seem to rationalize the large move this week and lack of correlation to bonds as a random act. Our "Trade of the Week" (short C) is now down by 5.5% or $3 since the trade was discussed in my Diary. Retail remains for sale. But my view is that a sentiment extreme is developing. Insurance stocks got whacked, including fav Hartford Financial (HIG) . Brokerages got hit, too. Goldman Sachs (GS) , put on Best Ideas List last week at $242, is down to $231. Biotech was lower, but not materially so (Celgene (CELG)Allergan (AGN) lower). Hwwever, spec biotech roiled to the downside (Intrexon (XON) , Ziopharm Oncology (ZIOP) , Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceuticals (AERI) ). Autos mixed. Ford (F) up, General Motors (GM) down. Good for our
RMPIA

updateJP Morgan Healthcare Conf.

Jan 9, 2017 | 7:21 AM EST
Thomson ONE
JPMorgan Healthcare Conference (Day 1 of 5) - 01/09/17 - 01/13/17 San Francisco, CA
RMPIA
By

Jim Cramer

 | Jan 6, 2017 | 12:15 PM EST
Jim Cramer breaks down why it is so difficult to buy drug stocks right now.
RMPIA
By

Doug Kass

 | Jan 3, 2017 | 3:33 PM EST
The U.S. dollar strengthened today, but closed well off the day's (spike) high. Oil vey! Crude down $1.46 after trading higher in the early going. Gold up $9. I like and added to my growing SPDR Gold Trust ETF (GLD) long. I discussed my rationale in my Bloomberg interview. Ag commodities: wheat down $0.01, corn up $0.04, soybeans down $0.08 and oats up $0.07. Lumber down $2. Bonds got schmeissed early on with 9-basis-point rise in the 10-year but the gain declined to only 2 basis points by day's end. The yield on the 10-year closed at about 2.45% (up 2 basis points) and the long-bond yield rose by less than 1 basis point. Municipals were for sale, but closed-end muni-bond funds ripped. Not sure why ... maybe just a cessation of tax selling. Junk wasn't junky and Blackstone/GSO Strategic Credit Fund (BGB) climbed by another $0.11. Banks were stronger, but off day's highs. If there was ever a consensus view of a sector, banks are it! Insurance was relatively quiet. I added to my Lincoln National (LNC) and Metlife (MET) shorts -- liking the reward vs. risk now. And I recently added to my Hartford Financial (HIG) long. Brokerages higher but well off highs, Goldman Sachs (GS) dramatically so. Old tech was quiet. Retail was lower but has begun to creep up late in the day. Autos had a nice showing in light of Trump Twitter storm. Biotech strong led by Celgene (CELG)Gilead Sciences (GILD) and my fav, Allergan. Merck (MCK) shorts were squeezed (up $8), but speculative biotech did little. Fertilizers flatlined as ag commodities were mixed. Consumer staples were mixed as the currency got stronger. Another up day for Campbell Soup (CPB) . Ag equipment up, with both Deere (DE) and Caterpillar (CAT) up a beaner. Shorted more Caterpillar as I favor upside/downside opportunity now. (T)FANG was very strong most of the day but is weakening as the day progresses. Alphabet (GOOGL)  up nicely. In individual stocks Oaktree Capital (OAK)  gained (maybe tax selling is over), DuPont (DD) holding well, along with Radian (RDN) . Apple (AAPL) didn't participate in the market rise.  Here are some value-added contributions on our site today:   1. Welcome back Jimmy! Jim "El Capitan" Cramer on the hit and miss parade. 2. Tom Graff on navigating the bond market.  3. "Meet" Bret Jensen on
RMPIA
By

Doug Kass

 | Dec 28, 2016 | 4:52 PM EST
The U.S. dollar firmed making a multi-month high against the euro earlier in the day. Crude oil was flat, closing right on the figure of $54 a barrel. Gold rose $4, and I re-established my long this week, although it's still small. Ag commodities were schmeissed for the second day in a row: Wheat down $0.075, corn down $0.065, soybeans down $0.08 and oats down $0.01. Lumber rose by nearly $5. Bonds had a spirited rally with TLT up a beaner. Closing at $118.70 I went long for a trade at $117.30 yesterday in anticipation of a Friday rebalancing on the part of pension plans (selling stocks, buying bonds because of the large differential of performance). Sir Arthur Cashin mentioned as much as $35 billion in stocks to sell. Stay tuned. Some might have been taken off today. The yield on the 10-year and long bond fell by about 5 basis points. The 10-year is approaching 2.5% (a two-week low). The 2s/10s spread flattened by 2-3 bps to 1256 basis points. Municipal bonds were well bid but closed-end muni-bond funds continue to be sold (more tax selling likely). Junk bonds were lower but Blackstone/GSO Strategic Credit Fund (BGB) went contra, up a large $0.10 to a recent high. I am not sure why the divergence because bank loan market didn't move much. Banks sold off and I re-established an Financial Select Sector SPDR Fund (XLF) short. A contrarian pay and consistent with my bond market expectations over the next few months. See 15 Surprises here and here. Insurance stocks got schmeissed. I am long Hartford Financial (HIG) and short Metlife (MET) and Lincoln National (LNC) (recent Best Idea List inclusions). Net net I made out fine in the space. Autos sold off. I plan to be a buyer of General Motors (GM) in a general market correction. Old media was sold. IBM (IBM) , short, down a buck. I recently added. Energy shares lower despite an unchanged crude oil price. Consumer staples were lower, save my long Campbell Soup (CPB) (that acts like a champ). Retail broadly on sale. JC Penney (JCP) held up well -- and I re-established some January and May short put positions taking in premium on a stock I like and would buy at lower levels). Biotech stunk with Gilead Sciences (GILD)  and Celgene (CELG)  both weak. Best Ideas new member, AGN was up $3 and I named it my favorite large-cap long for next year. Speculative biotech was clipped, too (Intrexon (XON) , Sage (SAGE) and ACADIA Pharma
RMPIA
By

Doug Kass

 | Dec 27, 2016 | 10:00 AM EST
Six reasons why the Nasdaq 100 ETF seems ready to pull back.
RMPIA
By

Doug Kass

 | Dec 27, 2016 | 7:00 AM EST
Microsoft (MSFT) , which makes up about 8.6% of the index. Amazon (AMZN) , which has about a 6.4% weighting. Cisco (CSCO) , which accounts for about 2.7% on QQQ. I've previously written that I'm bearish on Cisco on an intermediate-term basis. Non-Tech QQQ Stocks Look Iffy, Too Some non-tech QQQ components could weigh down the ETF in 2017 as well. These include biotech and health care companies such as Amgen (AMGN) , Biogen (BIIB) , Celgene (CELG) , Express Scripts (ESRX) and others, which all could suffer if Trump tries to limit drug-price increases. Comcast (CMCSA) also represents a relatively large QQQ weighting (about 3%), but the cable giant could suffer from continued "cord cutting" by consumers. Tax Cuts Won't Help QQQ Stocks Trump's plan to lower the effective U.S. corporate tax rate won't materially benefit QQQ components. After all, large tech and health care firms in the Nasdaq 100 already g
RMPIA
By

Doug Kass

 | Dec 22, 2016 | 3:18 PM EST
The U.S. dollar strengthened. The price of crude oil rose by two bits to almost $53 a barrel. Gold stunk up the joint, again, down by another $3 to $1,130. Ag commodities: wheat down $0.03, corn flat, sugar unchanged, soybeans down $0.12 and oats down $0.05. Lumber down $1. Bonds (on the short and long end rose by 1 basis point). The 2s/10s spread steepened by 2 basis points to 136 basis points, the widest spread since December a year ago. Municipals were offered. Junk was flat, Blackstone/GSO Strategic Credit Fund (BGB)  up $0.02. Banks held in brilliantly. Insurance was lower, though long Hartford Financial (HIG) was flat. Brokerages down modestly. Autos stalled and the stocks may be breaking out again after a tepid rally recently. Retails were the disaster du jour as the economic data was unfriendly (income disappointing and spending up). Meanwhile, the threat of export tariffs loom for the sector. I added to Kohl's (KSS) , Macy's (M) and JC Penney (JCP) today. Old tech was indifferent. Pharma phlat. Biotech down 1% (but Celge
RMPIA
By

Doug Kass

 | Dec 21, 2016 | 3:19 PM EST
The U.S. dollar weakened ever so slightly today. The price of oil faltered, dropping by $0.80 to $52.50/barrel. Gold flat-lined. I noticed that SPDR Gold Trust ETF (GLD) has been liquidated nearly 30 days in a row as we move towards an extreme bearish sentiment reading. Ag commodities: wheat down $0.025, corn down $0.03, soybean up $0.02 and oats up $0.01. Lumber down $4. Bonds rallied in price and declined in yield. The 10-year note fell by 2 basis points to 2.55%, and the long bond dropped by 3 basis points. The 2s/10s spread climbed by a tick to 134 basis points. Municipals rose modestly and closed-end muni-bond funds were mixed to lower. Junk bonds were better bid and Blackstone/GSO Strategic Credit Fund (BGB) fell by 2 basis points. Banks were unchanged. Brokerages slightly lower (Goldman Sachs (GS) down $2). Insurance mixed. Long Hartford Financial (HIG)  , which rose by nearly 1%. Autos mostly idled. Old tech was generally lower. Energy stocks were a bit higher, even though the commodity price was lower. Big pharma continues to dog it, led by a decline in Merck (MRK) . Biotech lost what it made on Tuesday. Allergan (AGN) was an upside feature, but Celgene (CELG) faltered and spec biotech was lower. Consumer staples were mixed. Campbell Soup (CPB) made a new high on the move, though. Ag equipment was lower. I am close to building up my Caterpillar (CAT) short again after this week's poor monthly retail sales data. Retail headed lower, but long JC Penney (JCP)  , which was up all day (though well off the highs). New longs Macy's (M) and Kohl's (KSS) sold off slightly. Fertilizers are returning to their old behavior ... acting like excre
RMPIA
By

Doug Kass

 | Dec 20, 2016 | 4:21 PM EST
The U.S. dollar's relentless climb continued -- now at $1.038 against the euro. This will cripple multi-nationals. For now, ignored. But we will begin to hear of corporate warnings (45% of S&P 500 earnings per share are non-U.S-based) shortly from this variable. There are several trillion dollars worth of U.S. dollar-based debt issued by non-U.S. entities. Another concern. The price of crude oil was relatively flat at $52.20, a gain of a dime. Gold down $10 to new lows at $1,132. Ag commodities generally weaker: wheat down $0.02, corn down $0.03, soybeans down $0.16 and oats down $0.02. Lumber up $4.50. Bonds wilted. The 10-year note yield rose 3 basis points and the long bond by a like amount. The 2s/10s spread expanded by another 3 basis points to 136 basis points. Munis were weaker but closed-end muni-bond funds were mixed. Junk bonds were unchanged, and Blackstone/GSO Strategic Credit Fun (BGB) rose by two pennies. Banks continued their monster mash. So did brokerages (led again by Goldman Sachs (GS) ) and insurance. Auto stocks were higher, but modestly so. Energy stocks were flat. Retail stocks rallied, on cue! Biotech up 1%, led by Celgene (CELG) and spec Acadia Pharmaceuticals (ACAD) (on good FDA news). Big pharma continues to stink up the joint. Broadly lower. Old tech was mixed. Good cover on trading short of Cisco Systems (CSCO) last week. Fertilizers mixed with Monsanto (MON) and Potash Corporation of Saskatchewan (POT) exchanging price performance from yesterday. Consumer staples succumbed to the stronger currency, but long Campbell Soup (CPB) made a new high on the move. Ag equipment was strong despite weak dealer data from Caterpillar (CAT) . (T)FANG was mixed and under-performed with Facebook (FB) and Netflix (NFLX) lower and Tesla (TSLA) , Amazon (AMZN) and Alphabet (GOOGL) higher. In individual names,
we are picking this up with the...
IBM (IBM)  reported numbers last night that, as expected, came in ahead of Wall Stree...
That 9.09% NYC MTA increase.... not reflected in your COLA (cost of living adjustment) for...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.